The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Researchers Engineer Light-Activated Cells for Treating Diabetes

    Article obtained from Photonics RSS Feed.

    Tufts University researchers have shown that glucose levels can be controlled in a mouse model of diabetes through optogenetics. When exposed to light, engineered pancreatic beta cells transplanted into diabetic mice produced more than two to three times the typical level of insulin.

    The light-switchable cells are designed to compensate for the lower insulin production or reduced insulin response found in diabetic individuals. The researchers sought to develop a new way to amplify insulin production while maintaining the important real-time link between the release of insulin and concentration of glucose in the bloodstream. Using optogenetics, they engineered pancreatic beta cells with a gene that encodes a photoactivatable adenylate…

    Nov, 05 2019 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.